New! Search for patents from more than 100 countries including Australia, Brazil, Sweden and more

FR2088019A1 - Esters of 2 and 6-substituted nicotinic acids - with vasomotor active - Google Patents

Esters of 2 and 6-substituted nicotinic acids - with vasomotor active

Info

Publication number
FR2088019A1
FR2088019A1 FR7016802A FR7016802A FR2088019A1 FR 2088019 A1 FR2088019 A1 FR 2088019A1 FR 7016802 A FR7016802 A FR 7016802A FR 7016802 A FR7016802 A FR 7016802A FR 2088019 A1 FR2088019 A1 FR 2088019A1
Authority
FR
France
Prior art keywords
ch2
active
vasomotor
esters
nicotinic acids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7016802A
Other versions
FR2088019B1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DAVID RABOT ETS FR
RABOT ETS DAVID
Original Assignee
DAVID RABOT ETS,FR
RABOT ETS DAVID
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by DAVID RABOT ETS,FR, RABOT ETS DAVID filed Critical DAVID RABOT ETS,FR
Priority to FR7016802A priority Critical patent/FR2088019B1/fr
Priority claimed from GB1249771A external-priority patent/GB1352415A/en
Publication of FR2088019A1 publication Critical patent/FR2088019A1/en
Application granted granted Critical
Publication of FR2088019B1 publication Critical patent/FR2088019B1/fr
Application status is Expired legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with heteroatoms or with carbon atoms having three bonds to hetero atoms, with at the most one to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one to halogen, e.g. ester or nitrile radicals
    • C07D213/79Acids; Esters
    • C07D213/80Acids; Esters in position 3

Abstract

Cpds. are of formula: (where R is aliphatic, araliphatic, heteroaliphatic or aminoalkyl; R2 and R6 = opt. substd. 1-20C aliphatic gps., alkenylaromatic, alkenylheterocyclic, alklaromatic, alkylheterocyclic. Prefd. gps. R are -A.B where B is dimethylamino, diethylamino, pyrrolidino, piperidino, hexamethyleneimino, morpholino, piperazino, N-methylpiperazino; A is -CH2-CH2- or -CH2.CH2-CH2-). Cpds. have vasomotor activity, active in animals at parenteral doses of 10 mg/kg.
FR7016802A 1970-05-08 1970-05-08 Expired FR2088019B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR7016802A FR2088019B1 (en) 1970-05-08 1970-05-08

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
FR7016802A FR2088019B1 (en) 1970-05-08 1970-05-08
GB1249771A GB1352415A (en) 1970-05-03 1971-04-30 Esters of substituted nicotine acids
ES71390924A ES390924A1 (en) 1970-05-03 1971-05-06 Process for the preparation of nicotinic acid derivatives.
BE766808A BE766808A (en) 1970-05-03 1971-05-06 New esters of nicotinic acid substituted

Publications (2)

Publication Number Publication Date
FR2088019A1 true FR2088019A1 (en) 1972-01-07
FR2088019B1 FR2088019B1 (en) 1974-08-30

Family

ID=9055254

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7016802A Expired FR2088019B1 (en) 1970-05-08 1970-05-08

Country Status (1)

Country Link
FR (1) FR2088019B1 (en)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2205515A1 (en) * 1972-11-08 1974-05-31 Hokuriku Pharmaceutical
US7199140B2 (en) 2001-06-26 2007-04-03 Astrazeneca Ab Vinyl phenyl derivatives as GLK activators
US7390908B2 (en) 2001-08-17 2008-06-24 Astrazeneca Ab Compounds effecting glucokinase
US7642263B2 (en) 2005-07-09 2010-01-05 Astrazeneca Ab Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetes
US7696191B2 (en) 2006-12-21 2010-04-13 Astrazeneca Ab Crystalline compound
US7700640B2 (en) 2004-10-16 2010-04-20 Astrazeneca Ab Process for making phenoxy benzamide compounds
US7709505B2 (en) 2002-11-19 2010-05-04 Astrazeneca Ab Benzofuran derivatives, process for their preparation and intermediates thereof
US7902200B2 (en) 2006-10-23 2011-03-08 Astrazeneca Ab Chemical compounds
US7973178B2 (en) 2005-11-28 2011-07-05 Astrazeneca Ab Chemical process for the preparation of an amido-phenoxybenzoic acid compound
US8071608B2 (en) * 2009-04-09 2011-12-06 Astrazeneca Ab Therapeutic agents

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200600086A (en) 2004-06-05 2006-01-01 Astrazeneca Ab Chemical compound
TW200714597A (en) 2005-05-27 2007-04-16 Astrazeneca Ab Chemical compounds
TW200825060A (en) 2006-10-26 2008-06-16 Astrazeneca Ab Chemical compounds
EA201100097A1 (en) 2008-08-04 2011-10-31 Астразенека Аб Derivatives of pyrazolo [3,4] pyrimidin-4-yl, and their use in the treatment of diabetes and obesity
GB0902434D0 (en) 2009-02-13 2009-04-01 Astrazeneca Ab Chemical process
GB0902406D0 (en) 2009-02-13 2009-04-01 Astrazeneca Ab Crystalline polymorphic form
AR076220A1 (en) 2009-04-09 2011-05-26 Astrazeneca Ab Pyrazole derivatives [4,5 - e] pyrimidine

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH458344A (en) * 1964-01-20 1968-06-30 Orgamol Sa A process for the preparation of basic esters of pyridine carboxylic acids
JPS644086A (en) * 1987-06-26 1989-01-09 Yokogawa Electric Corp Quantum resistance standard

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH458344A (en) * 1964-01-20 1968-06-30 Orgamol Sa A process for the preparation of basic esters of pyridine carboxylic acids
JPS644086A (en) * 1987-06-26 1989-01-09 Yokogawa Electric Corp Quantum resistance standard

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2205515A1 (en) * 1972-11-08 1974-05-31 Hokuriku Pharmaceutical
US7199140B2 (en) 2001-06-26 2007-04-03 Astrazeneca Ab Vinyl phenyl derivatives as GLK activators
US7390908B2 (en) 2001-08-17 2008-06-24 Astrazeneca Ab Compounds effecting glucokinase
US7524957B2 (en) 2001-08-17 2009-04-28 Astrazeneca Ab Compounds effecting glucokinase
US7951830B2 (en) 2001-08-17 2011-05-31 Astrazeneca Ab Compounds effecting glucokinase
US7709505B2 (en) 2002-11-19 2010-05-04 Astrazeneca Ab Benzofuran derivatives, process for their preparation and intermediates thereof
US7700640B2 (en) 2004-10-16 2010-04-20 Astrazeneca Ab Process for making phenoxy benzamide compounds
US7642259B2 (en) 2005-07-09 2010-01-05 Astrazeneca Ab Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetes
US7642263B2 (en) 2005-07-09 2010-01-05 Astrazeneca Ab Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetes
US7977328B2 (en) 2005-07-09 2011-07-12 Astrazeneca Ab Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetes
US7973178B2 (en) 2005-11-28 2011-07-05 Astrazeneca Ab Chemical process for the preparation of an amido-phenoxybenzoic acid compound
US7902200B2 (en) 2006-10-23 2011-03-08 Astrazeneca Ab Chemical compounds
US7696191B2 (en) 2006-12-21 2010-04-13 Astrazeneca Ab Crystalline compound
US8071608B2 (en) * 2009-04-09 2011-12-06 Astrazeneca Ab Therapeutic agents

Also Published As

Publication number Publication date
FR2088019B1 (en) 1974-08-30

Similar Documents

Publication Publication Date Title
GB1407065A (en) Production of security documents
JPS5246683A (en) Device for controlling a fluidized bed
FR2375235A1 (en) 3,7-Diaza:cyclo(3,3,1)nonane derivs. - having CNS activity, including central analgesic effect
DE2339715A1 (en) N-substd. 1-amino-3-phenyl-indane derivs. - useful as tranquillisers
FR2240734A1 (en) N-(dihydro sinapyl) piperazine derivs - having antiulcer, hypertensive and diuretic props
DE1534072A1 (en) Means for distributing and profiling the ballast of a railway track
FR2137186A1 (en) Folic acid salts - used as neuro-stimulants and for dynamising muscular function
FR2139628A1 (en) 5-(4-aryl piperazino-alkyl and alkylene) indans - with tranquillizing activity
USD209254S (en) Gate valve control
USD212670S (en) Figure
GB1348089A (en) 1-oxa-3,8diaza spiro-4,5-decane derivatives and processes for preparing them
USD212932S (en) Figure
USD205995S (en) Animal rake
Sen A study of Shakespeares prose
GB1215195A (en) Automatic continuous printing machine
USD190707S (en) Combined billfold and calendar
GB1474711A (en) Process for the incineration of contaminated salt-bearing solutions
BE797328R (en) Aminopropyl vincanols and eburnamines prepn - - by reaction of organo magnesium cpd with a vincanone or substd ebur
GB1127351A (en) Treatment of acidic condensates
GB1238957A (en)
AU1838767A (en) New biologically active derivatives of piperazine and process for the manufacture thereof
USD221444S (en) Table
Boleloucky A contribution to the problems of placebo dependence: Case report.
SU461134A1 (en) Inductor head for hardening products
USD233233S (en) Aerobic sewage treatment tank

Legal Events

Date Code Title Description
ST Notification of lapse